Litcius/Paper detail

Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten

Matteo Castrichini, Said Alsidawi, Jeffrey B. Geske, Darrell B. Newman, Adelaide M. Arruda‐Olson, J. Martijn Bos, Steve R. Ommen, Konstantinos C. Siontis, Michael J. Ackerman, John R. Giudicessi

2024Heart Rhythm30 citationsDOI

Topics & Concepts

MedicineHypertrophic cardiomyopathyAtrial fibrillationInternal medicineCardiologyCardiomyopathyObstructive cardiomyopathyPlaceboHeart failurePathologyAlternative medicineCardiomyopathy and Myosin StudiesCardiac pacing and defibrillation studiesCardiac Arrhythmias and Treatments
Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten | Litcius